What is ClaroNav?
ClaroNav specializes in cutting-edge navigation and restoration technologies tailored for dental and medical applications. The company's flagship products, Navident EVO and MicronMapper EVO, are designed to elevate precision and operational efficiency within dental practices. Beyond its direct product offerings, ClaroNav also develops innovative image-guided navigation systems that are characterized by their portability, cost-effectiveness, and adaptability for OEM clients. The core mission of ClaroNav is to enhance surgical procedure outcomes through a commitment to simplicity and accuracy in its technological solutions.
How much funding has ClaroNav raised?
ClaroNav has raised a total of $1.5M across 1 funding round:
Share Placement
$1.5M
Share Placement (2020): $1.5M, investors not publicly disclosed
What's next for ClaroNav?
The recent major strategic investment signals a pivotal growth phase for ClaroNav, likely enabling further research and development, market expansion, and enhancement of its product portfolio. This enterprise-level funding suggests a strategic focus on scaling operations and solidifying its market presence in the competitive medical technology landscape. Future developments may include broader adoption of its navigation systems across various surgical disciplines and potential partnerships for OEM solutions, leveraging its expertise in image guidance and precision technology.
See full ClaroNav company page
